Mereo BioPharma Group plc (AIM:MPH)
26.50
-0.50 (-1.85%)
At close: Dec 17, 2020
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of 28.14 million as of May 8, 2026. Its market cap has decreased by -90.82% in one year.
Market Cap
28.14M
Enterprise Value
-1.82M
Revenue
371.50K
Ranking
n/a
PE Ratio
n/a
Stock Price
26.50
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from 96.41M to 28.14M, a decrease of -70.81%. That is a compound annual growth rate of -16.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 28.14M | -42.88% |
| Dec 31, 2025 | 49.27M | -88.62% |
| Dec 31, 2024 | 433.05M | 70.57% |
| Dec 29, 2023 | 253.89M | 249.41% |
| Dec 30, 2022 | 72.66M | -43.40% |
| Dec 31, 2021 | 128.39M | -27.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lords Group Trading | 28.47M |
| Rome Resources | 28.37M |
| MicroSalt | 28.35M |
| Eden Research | 28.12M |
| Hercules | 27.80M |
| TheWorks.co.uk | 27.66M |
| CyanConnode Holdings | 27.63M |
| Inspiration Healthcare Group | 27.62M |